Clinical trial registry record

Skeletal Muscle Aging and Responsiveness in Aged People With MS

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated March 30, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07500727
Last registry update
March 30, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
Oklahoma Medical Research Foundation
Enrollment
10
Countries
United States
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NA · SINGLE GROUP · OTHER · NONE
Evidence population
Human clinical study registration
Participants
10
Population
ALL · 60 Years
Duration
2026-03-06 to 2026-12-31
Intervention
Exercise trial consisting of both cardiovascular and strength training
Comparator
Not reported
Outcomes measured
fMQ — Week -3 and Week -2; CRF — Enrollment to end of study at 18 weeks; Total and Regional Body Composition — Week -3 and Week -2; Muscle Biopsy — Week 1 and Week 12 Muscle Biopsy; Skeletal Muscle Phenotyping — Week 0, 6, and 12; Systemic Inflammation — Week 1 and Week 12; Muscle Inflammation — Week 1 and Week 12; Blood Biomarkers — Week 1 and Week 12; Mobility and Balance — Week -3 and Week -2; Basic Cognitive Function and Balance — Week -3 and Week -2; Participant's Self Evaluation of Physical, Mental, and Social Health — Week -3 and Week -2; Depression — Week -3 and Week -2; Circadian Rhythm — Week -3 and Week -2; Sleep Quality — Week -3 and Week -2; Fatigue — Week -3 and Week -2; Gait Speed — Week -3 and Week -2; Functional Capacity — Week -3 and Week -2; Phenotyping Support with Multidimensional Interindividual Response Heterogeneity — Week 1 through Week 13; Glucose Monitoring — Week 1 and Week 12; Dietary Intake — Week -3 to -2, Week 0, Week 6, and Week 12
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Sarcopenia · 80%Title contains controlled term: muscle aging. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

sarcopenia
Open primary sourceExport JSON